Optimizing safety and appropriateness of graft use in pelvic reconstructive surgery: Introduction to the 2nd IUGA grafts roundtable

International Urogynecology Journal

Volumn 23, Issue SUPPL. 1, 2012, Pages

  Davila, G Willy ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MEDICAL SOCIETY; PELVIC ORGAN PROLAPSE; PELVIC RECONSTRUCTIVE SURGERY; PELVIS SURGERY; PRIORITY JOURNAL; REVIEW; SURGEON; SURGICAL APPROACH; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; SURGICAL TRAINING; TISSUE GRAFT; VAGINA RECONSTRUCTION; WOUND HEALING;

EID: 84863090057     PISSN: 09373462     EISSN: 14333023     Source Type: Journal    
DOI: 10.1007/s00192-012-1676-4     Document Type: Review

References (18)

1. Shah AD, Kohli N, Rajan SS, Hoyte L (2008) The age, distribution, rate, and types of surgery for pelvic organ prolapse in the USA. Int Urogynecol J 19:421-428 (Pubitemid 351234036)
2. IUGA Grafts Roundtable (2005) Int Urogynecol J 17(Suppl 1):1-55, 2006
3. Davila GW, Drutz HP, Deprest J (2006) Clinical implications of the biology of grafts: conclusions of the 2005 IUGA Grafts Round-table. Int Urogynecol 17(Suppl 1):51-55
4. Morreim H, Mack MJ, Sade RM (2006) Surgical innovation: too risky to remain unregulated? Ann Thorac Surg 82:1957-1965 (Pubitemid 44781372)
5. Sung VW, Rogers RG, Schaffer JL et al (2008) Graft use in transvaginal pelvic organ prolapse repair: a systematic review. Obstet Gynecol 112:1131-1142
6. Jia X, Glazener C, Mowatt G et al (2008) Efficacy and safety of using mesh or grafts in surgery for anterior and/or posterior vaginal wall prolapse: systemic review and meta-analysis. BJOG 115:1350
7. Ganj FA, Ibeanu OA, Bedestani A, Nolan TE, Chesson RR (2009) Complications of transvaginal monofilament polypropylene mesh in pelvic organ prolapse repair. Int Urogynecol J 20:919-925
8. Boyles SH, McCrery R (2008) Dyspareunia and mesh erosion after vaginal mesh placement with a kit procedure. Obstet Gynecol 111:969-975 (Pubitemid 351482631)
9. Feiner B, Maher C (2010) Vaginal mesh contraction: definition, clinical presentation, and management. Obstet Gynecol 115:325-330
10. Ostergard DR (2007) Lessons from the past: directions for the future. Do new marketed surgical procedures and grafts produce ethical, personal liability, and legal concerns for physicians? Int Urogynecol J 18:591-598
11. Goldman HB, FitzGerald MP (2010) Opposing views: transvaginal mesh for cystocele repair. J Urol 183:430-432
12. Jacquetin B, Cosson M (2009) Complications of vaginal mesh use: our experience. Int Urogynecol J 20:893-896
13. Freeman RM, Lose G (2009) The great mesh debate. Int Urogynecol J 20:889-891
14. Murphy M (2008) Clinical practice guidelines on vaginal graft use from the Society of Gynecologic Surgeons. Obstet Gynecol 112:1123-1130
15. US Food and Drug Administration (2008) FDA public health notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence. July 13, 2011. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ PublicHealthNotifications/ucm061976.htm
16. HAS (2007) Evaluation des implants de renfort pour traitement de l'incontinence urinaire d'effort feminine et pour traitement du prolapsus des organes pelviens de la femme. Saint Denis, http://www.has-sante.fr
17. US Food and Drug Administration (2011) FDA safety communication: update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. US Food and Drug Administration. July 13, 2011. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm
18. Mukowski SJ, Jurnalov C, Phelps JY (2010) The use of vaginal mesh in the face of recent FDA warnings and litigation. Am J Obstet Gynecol 202:1.e1-1.e4